“Yield curve inversion won’t signal doom,” Jonathan Golub, chief U.S. equity strategist at Credit Suisse, said in a note last year. “While an inversion has preceeded each recession over the past 50 years, the lead time is extremely inconsistent, with a recession following anywhere from 14-34 months after the curve goes upside down.” The most
0 Comments
Photo: Humana.com 2011 Gain: $32.87 (60%) 2011 Closing price: $87.61 Last year, investors turned away from HMO stocks such as this, fearing the impact of a new health care overhaul rule involving medical-loss ratios. However, Humana showed it was able to manage the new regulation and in October delivered better-than-expected profits and a better-than-expected forecast
0 Comments
Tiffany shares bounced back Friday morning after management touted growth opportunities for the retailer, despite it reporting a 1 percent drop in sales worldwide during the holiday quarter, calling out “external challenges and uncertainties.” Its stock initially fell. But it was last up more than 3 percent following Tiffany’s earnings release, as its CEO soothed
0 Comments
CVS Health CEO Larry Merlo told CNBC Thursday that the health chain is unlocking growth opportunities despite the stock’s downward trend since officially merging with Aetna in November. The company has made “tactical execution” changes to its long-term care business that has faced “intense financial pressure,” he said. The skilled nursing unit came from CVS’
0 Comments
Nike shares tumbled Thursday following the sneaker maker reporting weaker-than-expected sales in North America during its fiscal third quarter, hurt, in part, by fewer people buying Converse-branded merchandise. Although its earnings topped analysts’ expectations, and total revenue was in-line with estimates, Nike shares sunk more than 4 percent after the bell on the news. The
0 Comments